News

Duke Neurology Research Round Up, January 2023

The final month of 2022 saw the release of 12 new peer-reviewed journal articles written or co-written by members of the Duke Neurology Department. Highlights of our most recent publications include an evaluation of a training program designed to improve the delivery of epilepsy care in Uganda, a review of recent advances in the treatment of carpal tunnel syndrome, and a discussion of treatment options for the autoimmune condition known as neuromyelitis optica spectrum disorder (NMOSD).

Duke Neurology 2022: A Year in Review (Part 2 of 2)

The Duke Neurology Department continued to build on its success in the second half of 2022. The final six months of 2022 saw Duke University Hospital receive national rankings for neurology and neurosurgery, our first endowed professorship dedicated to help treat and understand amyotrophic lateral sclerosis (ALS), and recognition as the country’s second national center of excellence for dystonia among other achievements.

Duke Neurology at AES 2022: Highlights from Nashville

Members of the Duke Neurology Department advanced the field of epilepsy care, research, and education at the 2022 meeting of the American Epilepsy Society (AES) in Nashville this week. This year, our faculty and trainees gave two lectures and co-authored eight new abstracts, for a total of more than 150 submissions from Duke to the AES since 2000.

Staff Spotlight: Skylar Groves

For as long as she can remember, Skylar Groves has been interested in the brain and in the nature of consciousness. Groves is currently putting those interests to use in the lab of Noreen Bukhari-Parlakturk, MD, PhD, where she is helping to examine how deep brain stimulation can help people with focal hand dystonia. In our latest Spotlight interview, Groves talks about her hopes of becoming a future neuroscientist and how her backgrounds in both chemistry and dance influence her current work.

Duke Neurology Research Round Up, November 2022

This October, members of the Duke Neurology Department advanced the fields of clinical and translational neuroscience, contributing to 14 new peer-reviewed studies and one book chapter. Highlights from our recent research include validation of new automated measures that evaluate handwriting for dystonia symptoms, a discussion of the effects of blood pressure on head and facial pain, and a discussion of presentations of a neuroimmune disorder known as MOGAD.

Staff Spotlight: Webb Pierson

Webb Pierson was an Aircraft Commander in the U.S. Navy in early 2021 when the COVID19 pandemic forced him and his fellow officers to isolate for two weeks before their deployment. Pierson used that time to reflect on his career, ultimately deciding to pursue a graduate studies in neuroscience and genomics. Now, Pierson is finishing up that graduate work while also running Duke NROTC program and conducting research in the lab of Ornit Chiba-Falek, PhD.

Unlocking the Secrets of Neurodegenerative Diseases

Duke Health leadership launched Translating Duke Health in 2017 as a multi-disciplinary, multi-year commitment to capitalize on Duke’s collective strengths in research, clinical care, and population health to address major health challenges.

Staff Spotlight: Zhaohui Man, MSIS

Genetic and epigenetic analysis offer the potential to vastly improve our understanding of how these conditions begin and progress, as well as to identify targets for future therapy. Bioinformatician Zhaohui Man, MS, MA, recently joined the lab of Ornit Chiba Falek, PhD, to perform this analysis and advance our understanding of Alzheimer’s, Parkinson’s, and other conditions.

Duke Neurology Research Round Up, September 2022

Members of the Duke Neurology Department contributed to 12 new peer-reviewed journal articles published this August. Highlights include a review article examining evoked potentials used for deep brain stimulation in Parkinson’s, the healthcare received by veterans with epilepsy, the optimal stroke treatments for patients with cerebral venous thrombosis, and other topics.